Resveratrol

Litaba

• Mohlomong e sebetsa bakeng sa ...
• Mohlomong ha e na thuso bakeng sa ...
• Bopaki bo sa lekaneng ba ho lekanya katleho ea ...
• Litlhokomelo le litemoso tse khethehileng:

Resveratrol ke k'hemik'hale e fumanoang veineng e khubelu, matlalo a morara o mofubelu, lero la morara o pherese, mulberry le ka bongata bo bokana ka matonkomane. E sebelisoa e le moriana.

Resveratrol e sebelisoa haholo bakeng sa cholesterol e phahameng, mofetše, lefu la pelo le maemo a mang a mangata. Leha ho le joalo, ha ho na bopaki bo matla bo tšehetsang ts'ebeliso ea resveratrol bakeng sa ts'ebeliso ena.

Meriana ea Tlhahisoleseling e Akaretsang e sebetsa hantle ho ipapisitsoe le bopaki ba mahlale ho latela sekala se latelang: E ​​ea sebetsa, e ka sebetsa hantle, mohlomong ea sebetsa, mohlomong e sa sebetse, mohlomong e sa sebetse, e sa sebetse ebile e sa lekana Bopaki bo lokelang ho lekanyetsoa.

Likarolo tsa katleho ea PUSELETSO LETS'ELA ke tse latelang:

Mohlomong e sebetsa bakeng sa ...

• Feberu. Ho sebelisa spray ea nko e nang le resveratrol makhetlo a mararo ka letsatsi bakeng sa libeke tse 4 ho bonahala ho fokotsa matšoao a ho kula ho batho ba baholo ba nang le ho kula ha linako tsa selemo. Ho sebelisa spray ea nko e nang le resveratrol le beta-glucans makhetlo a mararo ka letsatsi bakeng sa likhoeli tse 2 hape ho bonahala ho fokotsa matšoao a ho kula ho bana ba nang le ho kula hoa linako tsa selemo.
• Botenya. Liphuputso tse ling li bonts'a hore ho nka resveratrol ho ka eketsa tahlehelo ea boima ba 'mele ho batho ba baholo ba nang le botenya.

Mohlomong ha e na thuso bakeng sa ...

• Lefu la pelo. Batho ba jang li-resveratrol tse ngata haholo ha ba bonahale ba na le kotsi e tlase ea lefu la pelo ha ba bapisoa le batho ba jang chelete e tlase. Hape, ho nka resveratrol ka molomo ha ho bonahale ho ntlafatsa maemo a k'holeseterole kapa mafura a mali a bitsoang triglycerides ho batho ba kotsing ea lefu la pelo.
• Sehlopha sa matšoao a eketsang kotsi ea lefu la tsoekere, lefu la pelo le stroke (metabolic syndrome). Ho nka resveratrol ha ho bonahale eka ho theola khatello ea mali, tsoekere maling kapa k'holeseterole ho batho ba nang le ts'oaetso ea metabolism. Phuputso ea pele e bonts'a hore resveratrol e ka thusa ho fokotsa boima ba 'mele le mafura a' mele ho batho ba nang le metabolic syndrome. Empa ho hlokahala lipatlisiso tse ling ho netefatsa.
• Haha mafura sebeteng ho batho ba noang joala bo fokolang kapa ba sa bo noeng (lefu la sebete sa mafura a nonalcoholic kapa NAFLD). Boholo ba lipatlisiso tsa pele bo bonts'a hore resveratrol ha e ntlafatse ts'ebetso ea sebete, ho senya sebete kapa maemo a k'holeseterole ho batho ba nang le NAFLD.

Bopaki bo sa lekaneng ba ho lekanya katleho ea ...

• Makhopho. Phuputso ea pejana e bonts'a hore ho sebelisa gel e nang le resveratrol sefahlehong matsatsi a 60 ho fokotsa boima ba makhopho.
• Fokotsa bokhoni ba ho hopola le ho nahana bo etsahalang ka mokhoa o tloaelehileng le lilemo. Ha ho hlake hore na resveratrol e thusa ka mohopolo kapa tsebo ea ho nahana ho batho ba baholo. Liphuputso tse ling tsa pejana li bonts'a hore resveratrol e ka ntlafatsa bokhoni ba ho nahana le ho hopola ho basali kamora ho khaotsa ho ilela khoeli. Empa lipatlisiso tse ling li bonts'a hore resveratrol e fanoeng ka litekanyetso tse phahameng kapa ka nako e teletsana ha e ntlafatse mohopolo kapa tsebo ea ho nahana ho batho ba baholo ba phetseng hantle.
• Boloetse ba mali bo fokotsang liprotheine maling a bitsoang hemoglobin (beta-thalassemia). Phuputso ea pejana e bonts'a hore ho nka trans-resveratrol ha ho ntlafatse maemo a hemoglobin kapa tlhoko ea ho tšeloa mali ho batho ba nang le beta-thalassemia.
• Kankere. Batho ba jang li-resveratrol tse ngata tsa lijo ha ba bonahale ba na le kotsi e tlase ea mofets'e ha ba bapisoa le batho ba jang chelete e tlase.
• Lefu la tsoekere. Phuputso e 'ngoe e bonts'a hore resveratrol e ntlafatsa taolo ea tsoekere maling ho batho ba nang le lefu la tsoekere. Empa lipatlisiso tse ling ha li bontše molemo. Resveratrol e ka thusa ho theola tsoekere maling feela ho bakuli ba nang le tsoekere e sa laoloang hantle. Ho hlokahala lipatlisiso tse ling ho netefatsa.
• Tšenyo ea liphio ho batho ba nang le lefu la tsoekere (lefu la tsoekere nephropathy). Phuputso ea pejana e bonts'a hore ho noa resveratrol le losartan ea lithethefatsi ho ka ntlafatsa mehato e meng ea tšenyo ea liphio ho batho ba nang le lefu la tsoekere.
• Lefu la matšoafo le etsang hore ho be thata ho hema (boloetse bo sa foleng ba pulmonary pulmonary kapa COPD). Phuputso ea pele e fana ka maikutlo a hore ho nka sehlahisoa se kopaneng se nang le resveratrol, vithamine C, zinki le flavonoids ho fokotsa ho khohlela le tlhahiso ea mamina ho batho ba nang le COPD. Empa ha ho hlake hore na molemo o bakoa ke resveratrol kapa metsoako e meng.
• Osteoarthritis. Phuputso ea pele e bonts'a hore ho eketsa resveratrol kalafong e tloaelehileng bakeng sa masapo a masapo a mangole ho ka ntlafatsa bohloko, ts'ebetso le ho satalla ho feta kalafo e tloaelehileng feela.
• Ho ntlafatsa ts'ebetso ea bongaka e bitsoang peritoneal dialysis. Phuputso ea pele e bonts'a hore resveratrol e kanna ea etsa hore ho sefa mali ho tsamaee kapele ho batho ba nang le peritoneal dialysis.
• Bothata ba li-hormone bo bakang mae a bomme a atolositsoeng ka li-cysts (polycystic ovary syndrome kapa PCOS). Phuputso ea pele e bonts'a hore resveratrol e fokotsa testosterone ho basali ba nang le PCOS. Empa ha e ntlafatse boima, litekanyetso tsa lipid, makhopho, kapa kholo ea moriri e sa batleheng ho basali ba nang le boemo bona.
• Ramatiki ea ramatiki (RA). Ho nka resveratrol hammoho le lithethefatsi bakeng sa RA ho bonahala ho fokotsa palo ea manonyeletso a bohloko le a ruruhileng. Empa ha ho tsejoe hore na resveratrol e boetse e thusa ho fokotsa tšenyo e kopaneng.
• Mofuta oa lefu la ho ruruha ha mala (ulcerative colitis). Phuputso ea pele e bonts'a resveratrol e kanna ea ntlafatsa matšoao le ho fokotsa ts'ebetso ea ulcerative colitis.
• Letlalo le tsofalang.
• Fokotsa bokhoni ba ho hopola le ho nahana ho batho ba baholo ho feta se tloaelehileng ho lilemo tsa bona.
• Ho thatafala ha methapo (atherosclerosis).
• Tsebo ea ho hopola le ho nahana (ts'ebetso ea kelello).
• Maemo a mang.

Ho hlokahala bopaki bo bongata ho lekanya resveratrol bakeng sa ts'ebeliso ena.

Resveratrol e kanna ea holisa methapo ea mali le ho fokotsa ts'ebetso ea lisele tse bohlokoa ho koalang mali. Phuputso e 'ngoe e bontša hore resveratrol e na le litlamorao tse fokolang tsa estrogen (hormone ea basali). E ka boela ea fokotsa bohloko le ho ruruha (ho ruruha). Resveratrol e ka fokotsa maemo a tsoekere (glucose) maling le ho thusa 'mele ho loants'a mafu. E kanna ea boela ea thibela liprotheine bokong hore li se ke tsa khomarelana ho thusa ho thibela mafu a joalo ka lefu la Alzheimer's.

Ha e nkoa ka molomo: Resveratrol ke TŠOANANG POLOKO ha e sebelisoa ka bongata bo fumanoang lijong. Ha e nooa ka litekanyetso ho fihlela ho 1500 mg letsatsi le letsatsi ho fihlela likhoeli tse 3, resveratrol ke MOTS'ELISI TS'IU. Litekanyo tse phahameng ho fihlela 2000-3000 mg letsatsi le letsatsi li sebelisitsoe ka mokhoa o sireletsehileng bakeng sa likhoeli tse 2-6. Leha ho le joalo, litekanyetso tsena tse phahameng tsa resveratrol li na le monyetla oa ho baka mathata a mala.

Ha e sebelisoa letlalong: Resveratrol ke MOTS'ELISI TS'IU ha e sebelisoa letlalong ho fihlela matsatsi a 30.

Litlhokomelo le litemoso tse khethehileng:

Bokhachane le ho anyesa: Resveratrol ke TŠOANANG POLOKO ha e sebelisoa ka bongata bo fumanoang lijong tse ling. Leha ho le joalo, nakong ea bokhachane le ho anyesa, mohloli oa resveratrol o bohlokoa. Resveratrol e fumanoa ka matlalo a morara, lero la morara, veine le mehloli e meng ea lijo. Veine ha ea lokela ho sebelisoa e le mohloli oa resveratrol nakong ea bokhachane le ho anyesa.

Bana: Resveratrol ke MOTS'ELISI TS'IU ho bana ha ba nyanyatsoa linkong ho fihlela likhoeli tse 2.

Mathata a ho tsoa mali: Resveratrol e ka liehisa ho koala mali le ho eketsa menyetla ea ho tsoa mali ho batho ba nang le mathata a ho tsoa mali.

Boemo bo mamelang Hormone joalo ka mofets'e oa matsoele, mofetše oa popelo, mofetše oa ovari, endometriosis, kapa uterine fibroids: Resveratrol e ka sebetsa joalo ka estrogen. Haeba u na le boemo bofe kapa bofe bo ka mpefatsoang ke ho pepesehela estrogen, u se ke ua sebelisa resveratrol.

Phekolo: Resveratrol e ka eketsa menyetla ea ho tsoa mali nakong le kamora 'opereishene. Khaotsa ho sebelisa resveratrol bonyane libeke tse 2 pele ho opereishene e reriloeng.

E itekanetse

E-ba hlokolosi ka motsoako ona.

Meriana e fetotsoeng ke sebete (likaroloana tsa Cytochrome P450 1A1 (CYP1A1))

Meriana e meng ea fetoloa ebe ea robeha sebeteng. Resveratrol e ka fokotsa hore na sebete se senya meriana kapele hakae. Ka khopolo, ho nka resveratrol hammoho le meriana e robehileng sebeteng ho ka eketsa litlamorao le litlamorao tsa meriana e meng.

Meriana e meng e fetotsoeng ke sebete e kenyelletsa chlorzoxazone, theophylline le bufuralol.

Meriana e fetotsoeng ke sebete (likaroloana tsa Cytochrome P450 1A2 (CYP1A2))

Meriana e meng ea fetoloa ebe ea robeha sebeteng. Resveratrol e ka fokotsa hore na sebete se senya meriana kapele hakae. Ka khopolo, ho nka resveratrol hammoho le meriana e robehileng sebeteng ho ka eketsa litlamorao le litlamorao tsa meriana e meng.

Meriana e meng e fetotsoeng ke sebete e kenyelletsa clozapine (Clozaril), cyclobenzaprine (Flexeril), fluvoxamine (Luvox), haloperidol (Haldol), imipramine (Tofranil), mexiletine (Mexitil), olanzapine (Zyprexa), pentazocine (Talwin) propran ), tacrine (Cognex), zileuton (Zyflo), zolmitriptan (Zomig), le tse ling.

Meriana e fetotsoeng ke sebete (likaroloana tsa Cytochrome P450 1B1 (CYP1B1))

Meriana e meng ea fetoloa ebe ea robeha sebeteng. Resveratrol e ka fokotsa hore na sebete se senya meriana kapele hakae. Ka khopolo, ho nka resveratrol hammoho le meriana e robehileng sebeteng ho ka eketsa litlamorao le litlamorao tsa meriana e meng.

Meriana e meng e fetotsoeng ke sebete e kenyelletsa theophylline, omeprazole, clozapine, progesterone, lansoprazole, flutamide, oxaliplatin, erlotinib le caffeine.

Meriana e fetotsoeng ke sebete (likaroloana tsa Cytochrome P450 2C19 (CYP2C19))

Meriana e meng ea fetoloa ebe ea robeha sebeteng. Resveratrol e ka fokotsa hore na sebete se senya meriana kapele hakae. Ka khopolo, ho nka resveratrol hammoho le meriana e robehileng sebeteng ho ka eketsa litlamorao le litlamorao tsa meriana e meng.

Meriana e meng e fetotsoeng ke sebete e kenyelletsa amitriptyline (Elavil), carisoprodol (Soma), citalopram (Celexa), diazepam (Valium), lansoprazole (Prevacid), omeprazole (Prilosec), phenytoin (Dilantin), warfarin le tse ling tse ngata.

Meriana e fetotsoeng ke sebete (likaroloana tsa Cytochrome P450 2E1 (CYP2E1))

Meriana e meng ea fetoloa ebe ea robeha sebeteng. Resveratrol e ka fokotsa hore na sebete se senya meriana kapele hakae. Ka khopolo, ho nka resveratrol hammoho le meriana e robehileng sebeteng ho ka eketsa litlamorao le litlamorao tsa meriana e meng.

Meriana e meng e fetotsoeng ke sebete e kenyelletsa acetaminophen, chlorzoxazone (Parafon Forte), ethanol, theophylline, le anesthetics tse kang enflurane (Ethrane), halothane (Fluothane), isoflurane (Forane), methoxyflurane (Penthrane).

Meriana e fetotsoeng ke sebete (likaroloana tsa Cytochrome P450 3A4 (CYP3A4))

Meriana e meng ea fetoloa ebe ea robeha sebeteng. Resveratrol e ka fokotsa hore na sebete se senya meriana kapele hakae. Ka khopolo, ho nka resveratrol hammoho le meriana e robehileng sebeteng ho ka eketsa litlamorao le litlamorao tsa meriana e meng. Leha ho le joalo, lipatlisiso tse ling tsa pejana li bonts'a sephetho se loantšanang.

Meriana e meng e fetotsoeng ke sebete e kenyelletsa li-blocker tsa calcium channel (diltiazem, nicardipine, verapamil), chemotherapeutic agents (etoposide, paclitaxel, vinblastine, vincristine, vindesine), li-antifungals (ketoconazole, itraconazole), glucocorticoids, alfentanil (Alfenta) ), fentanyl (Sublimaze), lidocaine (Xylocaine), losartan (Cozaar), fexofenadine (Allegra), midazolam (Versed), le tse ling.

Meriana e liehang ho koala mali (Anticoagulant / Antiplatelet drug)

Resveratrol e ka liehisa ho koala mali. Ho nka resveratrol hammoho le meriana e fokotsang ho koala butle ho ka eketsa menyetla ea ho longoa le ho tsoa mali.

Meriana e meng e liehang ho koala mali e kenyelletsa aspirin, clopidogrel (Plavix), diclofenac (Voltaren, Cataflam, tse ling), ibuprofen (Advil, Motrin, ba bang), naproxen (Anaprox, Naprosyn, tse ling), dalteparin (Fragmin), enoxaparin (Lovenox) , heparin, warfarin (Coumadin), le tse ling.

Litlama le litlatsetso tse ka fokotsang ho hoama ha mali (Anticoagulant / Antiplatelet herbs and supplements)

Resveratrol e ka liehisa ho koala mali. Ho e sebelisa hammoho le litlama tse ling kapa litlatsetso tse ka fokotsang ho hoama ha mali ho ka eketsa kotsi ea ho tsoa mali kapa ho longoa ke batho ba bang. Litlama tsena li kenyelletsa angelica, clove, danshen, feverfew, konofolo, ginger, ginkgo, ginseng Panax, chestnut ea pere, red clover, turmeric le tse ling.

Mafura le lijo tse nang le mafura

Ho nka resveratrol ka lijo tse nang le mafura a mangata ho ka fokotsa palo ea resveratrol e monyang 'mele.

Litekanyo tse latelang li ithutiloe lipatlisisong tsa mahlale:

BAHOLO

KA MOLOMO:

• Bakeng sa ho kula ha linako tsa selemo (hay fever): Metsoako e 'meli ea lero la noka ea 0.1% ea resveratrol ka nko ka' ngoe makhetlo a mararo / letsatsi ho fihlela libeke tse 4.
• Bakeng sa botenya: 500 mg kapa ka tlase ho resveratrol letsatsi le letsatsi ka likhoeli tse 3 kapa ho feta.

3,5,4 'TriHydroxy-Transstibene, (E) - 5- (4-hydroxystyryl) benzene-1,3-diol, 3,4', 5-stilbenetriol, 3,5,4 '-trihydroxystilbene, 3,4 ', 5-trihydroxystilbene, 3,5,4'-trihydroxy-trans-stilbene, Cis-Resveratrol, Extrait de Vin, Extrait de Vin Rouge, Kojo-Kon, Phytoalexin, Phytoalexine, Phytoestrogen, Phyto-œstrogène, Pilule de Vin Protykin, ntšang Veine e khubelu, Resvératrol, Resveratrols, Resvératrols, RSV, RSVL, Stilbene Phytoalexin, Trans-Resveratrol, Trans-Resvératrol, Veine ntšang, pilisi ea Veine.

Ho ithuta haholoanyane ka hore na sengoloa sena se ngotsoe joang, ka kopo bona Meriana ea Tlhahisoleseling e Akaretsang mokhoa.

1. Zhang N, Liang T, Jin Q, Shen C, Zhang Y, Jing P. Chinese yam (Dioscorea opposita Thunb.) E fokotsa letšollo le amanang le lithibela-mafu, e fetola mala a microbiota, mme e eketsa boemo ba mafura a ketane e khuts'oane ho litoeba. Lijo Res Int. 2019; 122: 191-198. Sheba tse sa hlakang.
2. Akbari M, Tamtaji OR, Lankarani KB, et al. Litholoana tsa tlatsetso ea resveratrol mabapi le ts'ebetso ea ho qetela le khatello ea mali har'a bakuli ba nang le ts'oaetso ea metabolic le mathata a amanang le ona: tlhahlobo e hlophisitsoeng le tlhahlobo ea litlhahlobo tsa liteko tse laoloang ka linako tsohle. Khatello ea mali e Phahameng Cardiovasc Pele ho 2019; 26: 305-19. Sheba tse sa hlakang.
3. Köbe T, Witte AV, Schnelle A, le al. Kameho ea resveratrol taolong ea tsoekere, sebopeho sa hippocampal le khokahano, le ts'ebetso ea mohopolo ho bakuli ba nang le ts'oaetso e bonolo ea kutloisiso. Ka pele Neurosci 2017; 11: 105. Sheba tse sa hlakang.
4. Witte AV, Kerti L, Margulies DS, Flöel A. Liphello tsa resveratrol ts'ebetsong ea mohopolo, khokahanyo e sebetsang ea hippocampal, le metabolism ea glucose ho batho ba baholo ba phetseng hantle. J Neurosci 2014; 34: 7862-70 (Khatisitsoeng) Sheba tse sa hlakang.
5. Mousavi SM, Milajerdi A, Sheikhi A, et al. Tlatsetso ea Resveratrol e susumetsa haholo mehato ea botenya: tlhahlobo e hlophisehileng le tlhahlobo ea litlhahlobo tsa litlhahlobo tsa liteko tse laoloang ka linako tsohle. Obes Tšenolo 2019; 20: 487-98. Sheba tse sa hlakang.
6. Sattarinezhad A, Roozbeh J, Shirazi Yeganeh B, Omrani GR, Shams M. Resveratrol e fokotsa albinuria ka lefu la tsoekere: teko ea kliniki e laoloang ka bobeli e sa boneng. Lefu la tsoekere Metab 2019; 45: 53-9. Sheba tse sa hlakang.
7. Zhang C, Yuan W, Fang J, Wang W, He P, Lei J, Wang C. Ts'ebetso e ntle ea Resveratrol Supplementation khahlano le Mafu a Sebele a sa Tseng Joala a Meta: Tlhatlhobo ea Meta-Tlhahlobo ea Liteko tsa Kliniki tse Laoloang ke Placebo. PLoS E le 'ngoe. 2016 Aug 25; 11: e0161792. Sheba tse sa hlakang.
8. Poulsen MK, Nellemann B, Bibby BM, le al. Ha ho na phello ea resveratrol ho VLDL-TG kinetics le kutloisiso ea insulin ho banna ba batenya haholo ba nang le lefu la sebete le se nang joala. Lefu la tsoekere la Obes Metab. 2018; 20: 2504-2509. Sheba tse sa hlakang.
9. Hussain SA, Marouf BH, Ali ZS, Ahmmad RS. Ts'ebetso le polokeho ea ts'ebelisano 'moho ea resveratrol le meloxicam ho bakuli ba nang le lefu la masapo a mangole: boithuto bo kenellang ba mofofisi. Botsofali ba Tleliniki. 2018; 13: 1621-1630. Sheba tse sa hlakang.
10. Huhn S, Beyer F, Zhang R, le al. Liphello tsa resveratrol ts'ebetsong ea mohopolo, khokahanyo ea hippocampus le microstructure ho batho ba baholo - Teko e laoloang ka linako tsohle. Puo ea morao-rao. 2018; 174: 177-190. Sheba tse sa hlakang.
11. Haghpanah S, Zarei T, Eshghi P, le al. Ts'ebetso le polokeho ea resveratrol, e leng moemeli oa hemoglobin F-augmenting agent, ho bakuli ba beta-thalassemia intermedia. Ann Hematol. 2018; 97: 1919-1924. Sheba tse sa hlakang.
12. Anton SD, Ebner N, Dzierzewski JM, le al. Liphello tsa Matsatsi a 90 a Tlatsetso ea Resveratrol mabapi le Ts'ebetso ea Temoho ho Baholo: Boithuto ba Pilot. J Altern Complement Med. 2018; 24: 725-732. Sheba likhetho.
13. Lv C, Zhang Y, Shen L. Tlhahlobo ea pele ea kliniki ea ts'ebetso ea resveratrol ho batho ba baholo ba nang le allergic rhinitis. Int Arch Ts'oaetso ea Immunol 2018; 175: 231-6. Sheba tse sa hlakang.
14. Zortea K, Franco VC, Francesconi LP, Cereser KM, Lobato MI, Belmonte-de-Abreu PS. Tlatsetso ea Resveratrol ho Bakuli ba Schizophrenia: Tlhahlobo ea Tleliniki e Randomized e Hlahlobang Serum Glucose le Lisosa tsa Likotsi Tsa Pelo. Metsoako. 2016; 8: 73. Sheba tse sa hlakang.
15. Wightman EL, Haskell-Ramsay CF, Reay JL, le al. Litholoana tsa tlatsetso e sa foleng ea trans-resveratrol likarolong tsa ts'ebetso ea kelello, maikutlo, boroko, bophelo bo botle le phallo ea mali bokong ho batho ba bacha ba phetseng hantle. Br J Phepo. 2015; 114: 1427-37. Sheba tse sa hlakang.
16. Turner RS, Thomas RG, Craft S, et al. Teko e laoloang ka li-placebo ea resveratrol bakeng sa lefu la Alzheimer. Neurology. 2015; 85: 1383-91. Sheba tse sa hlakang.
17. Linako S, de Ligt M, Phielix E, et al. Resveratrol e le Phekolo ea Tlatsetso ho Lihlooho tse nang le Mofuta oa 2 oa lefu la tsoekere le laoloang hantle: Teko e laoloang ka nako e sa lekanyetsoang. Tlhokomelo ea lefu la tsoekere. 2016; 39: 2211-2217. Sheba tse sa hlakang.
18. Samsami-Kor M, Daryani NE, Asl PR, Hekmatdoost A. Litlamorao tse khahlano le ho ruruha tsa Resveratrol ho bakuli ba nang le Ulcerative Colitis: Thupelo ea Pilot e laoloang, e foufetseng habeli, e laoloang ke Placebo. Arch Med Res. 2015; 46: 280-5. Sheba tse sa hlakang.
19. Lin CT, Letsatsi la XY, Lin AX. Tlatsetso ka trans-resveratrol e nang le lethal dose e phahameng e ntlafatsa ultrafiltration ho bakuli ba peritoneal dialysis: thuto e lebelletsoeng, e sa sebetseng, e habeli. Ren o Hlōlehile. 2016; 38: 214-21. Sheba tse sa hlakang.
20. Kjaer TN, Ornstrup MJ, Poulsen MM, le al. Resveratrol e fokotsa maemo a ho potoloha li-precursor tsa androgen empa ha e na phello ho, testosterone, dihydrotestosterone, maemo a PSA kapa bophahamo ba senya. Teko ea likhoeli tse 4 ea banna ba lilemong tse bohareng. Tšoelesa ea senya. 2015; 75: 1255-63. Sheba tse sa hlakang.
21. Evans HM, Howe PR, Wong RH. Liphello tsa Resveratrol mabapi le Ts'ebetso ea Kelello, Mood le Cerebrovascular Function ho Basali ba Post-Menopausal; Teko ea ho kenella e laoloang ka nako ea libeke tse 14. Metsoako. 2017; 9. Sheba tse sa hlakang.
22. Elgebaly A, Radwan IA, AboElnas MM, le al. Tlatsetso ea Resveratrol ho bakuli ba nang le Mafu a Sebete a sa Neng Joala: Tlhahlobo ea Ts'ebetso le Tlhatlhobo ea Meta. J Gastrointestin Sebete Dis. 2017; 26: 59-67.Sheba tse sa hlakang.
23. Bo S, Ponzo V, Ciccone G, et al. Likhoeli tse tšeletseng tsa tlatsetso ea resveratrol ha e na phello e lekantsoeng ho bakuli ba 2 ba nang le lefu la tsoekere. Teko e laoloang ea "placebo" e sa sebetseng, e habeli e foufetseng Phekolo ea Pharmacol Res. 2016; 111: 896-905. Sheba tse sa hlakang.
24. Bedada SK, Neerati P. Resveratrol Pretreatment e ama CYP2E1 Ketsahalo ea Chlorzoxazone ho Baithaopi ba Batho ba Phetseng Hantle. Phytother Res. 2016; 30: 463-8. Sheba tse sa hlakang.
25. Banaszewska B, Wrotynska-Barczynska J, Spaczynski RZ, Pawelczyk L, Duleba AJ. Liphello tsa Resveratrol ho Polycystic Ovary Syndrome: Teko e Laoloang habeli, e Randomized, e Laoloang ke Placebo. J Kliniki ea Endocrinol Metab. 2016; 101: 4322-4328. Sheba tse sa hlakang.
26. Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol e le kalafo e sebetsang ea adjuvant taolong ea ramatiki ea mafu: thuto ea bongaka. Kliniki ea Rheumatol. 2018; [Epub pele ho khatiso]. Sheba tse sa hlakang.
27. Shishodia S, Aggarwal BB. Resveratrol: polyphenol bakeng sa linako tsohle tsa selemo. Resveratrol ka bophelo bo botle le mafu. Boca Raton, FL: CRC Press, 2005.
28. Creasy LL, Kofi M. Phytoalexin tlhahiso ea monyetla oa monokotšoai oa morara. J Am Soc Hortic Sci. 1988; 113: 230-234.
29. Langcake P, McCarthy W. Kamano ea tlhahiso ea resveratrol le tšoaetso ea makhasi a morara oa Botrytis cinerea. Sefuba. 1979; 18: 244-253.
30. Theko NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, Sinclair DA. SIRT1 e hlokahala bakeng sa ts'ebetso ea AMPK le litlamorao tse ntle tsa resveratrol ts'ebetsong ea mitochondrial. Cell Metab. 2012 Mots'eanong 2; 15: 675-90. Sheba tse sa hlakang.
31. Wang S, Moustaid-Moussa N, Chen L, Mo H, Shastri A, Su R, Bapat P, Kwun I, Shen CL. Tlhaloso ea libuka tsa lijo tsa polyphenols le botenya. J Nutriti ea Likokoana-hloko. 2014 Jan; 25: 1-18. Sheba tse sa hlakang.
32. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E. Thibelo ea ntaramane A phetiso ea vaerase ka resveratrol. J Ho Kula Dis. 2005 la 15 Motšeanong; 191: 1719-29. Sheba tse sa hlakang.
33. Mastromarino P, Capobianco D, Cannata F, Nardis C, Mattia E, De Leo A, Restignoli R, Francioso A, Mosca L. Resveratrol e thibela ho pheta-pheta ha li-rhinovirus le polelo ea baemeli ba hlabang ba nasal epithelia. Antiviral Res. 2015 Nov; 123: 15-21. Sheba tse sa hlakang.
34. Crowell JA, Korytko PJ, Morrissey RL, Booth TD, Levine BS. Phekolo ea renal e amanang le Resveratrol. Toxicol Sci. Phato ea 2004; 82: 614-9. Sheba tse sa hlakang.
35. Semba RD, Ferrucci L, Bartali B, Urpí-Sarda M, Zamora-Ros R, Sun K, Cherubini A, Bandinelli S, Andres-Lacueva C. Maemong a Resveratrol le tsohle tse bakang lefu ho batho ba baholo ba lulang sechabeng. JAMA Ka hare Med. 2014 Phupu; 174: 1077-84. Sheba tse sa hlakang.
36. Sahebkar A. Liphello tsa tlatsetso ea resveratrol ho li-plasma lipids: tlhahlobo e hlophisehileng le tlhahlobo ea litlhahlobo tsa liteko tse laoloang ka linako tsohle. Metsoako Rev. 2013 Dec; 71: 822-35. Sheba tse sa hlakang.
37. Miraglia Del Giudice M, Maiello N, Capristo C, Alterio E, Capasso M, Perrone L, Ciprandi G. Resveratrol hammoho le carboxymethyl-ß-glucan e fokotsa matšoao a nko ho bana ba nang le peo e phofshoana e bakoang ke peo e phofshoana. Curr Med Res Opin. 2014 Mphalane; 30: 1931-5. Sheba tse sa hlakang.
38. Méndez-del Villar M, González-Ortiz M, Martínez-Abundis E, Pérez-Rubio KG, Lizárraga-Valdez R. Phello ea tsamaiso ea resveratrol ho metabolic syndrome, insulin sensitivity, le insulin secretion. Phetoho ea Metab Syndr. Selemo sa 2014; 12: 497-501. Sheba tse sa hlakang.
39. Magyar K, Halmosi R, Palfi A, Feher G, Czopf L, Fulop A, Battyany I, Sumegi B, Toth K, Szabados E. Cardioprotection by resveratrol: Teko ea kliniki ea motho ho bakuli ba nang le methapo ea methapo e tsitsitseng. Kliniki ea Hemorheol Microcirc. 2012; 50: 179-87. Sheba tse sa hlakang.
40. Liu K, Zhou R, Wang B, Mi MT. Phello ea resveratrol taolong ea tsoekere le kutloisiso ea insulin: meta-analysis ea liteko tse 11 tse laoloang ka linako tsohle. Am J Lithethefatsi tsa Kliniki. 2014 Jun; 99: 1510-9. Sheba tse sa hlakang.
41. Faghihzadeh F, Adibi P, Rafiei R, Hekmatdoost A. Resveratrol supplementation e ntlafatsa li-biomarkers tsa ho ruruha ho bakuli ba nang le lefu la sebete le se nang joala. Nut ea Res. 2014 Mphalane; 34: 837-43. Sheba tse sa hlakang.
42. Chachay VS, Macdonald GA, Martin JH, Whitehead JP, O'Moore-Sullivan TM, Lee P, Franklin M, Klein K, Taylor PJ, Ferguson M, Coombes JS, Thomas GP, Cowin GJ, Kirkpatrick CM, Prins JB, Hickman IJ. Resveratrol ha e thuse bakuli ba nang le lefu la sebete le mafura a nonalcoholic. Kliniki ea Gastroenterol Hepatol. Selemo sa 2014; 12: 2092-103.e1-6. Sheba tse sa hlakang.
43. Hudson, GM, Shelmadine, B., Cooke, M., Genovese, J., Greenwood, M., le Willoughby, DS Resveratrol Supplementation le Liphetoho ho Glucose, Insulin, Le Tlhaloso ea mRNA Ka mor'a ho ikoetlisa ho basali ba nang le boima bo feteletseng: 2467. Medicine & Saense ho Lipapali le Boikoetliso 2011; 43
44. Guarnieri, R., Pappacoda, A., le Solitro, S. [Resveratrol e nang le motsoako e fokotsa khatello ea mali le ho matlafatsa matšoao a bongaka lithutong tsa COPD] Un composto a base di resveratrolo riduce lo stress ossidativo e migliora la sintomatologia clinica in soggetti con BPCO . Cochrane Central Register ea Liteko tse Laoloang 2009;
45. Yoon, SJ, Cho, KS, Lee, YH, Kim, DS, le Hong, SJ RESVERATROL E Thibela CXCR4 MEDIATED TUMOR KHOLO LE HO FIHLELA KA SELLE SA Kankere EA BATHO HO VITRO LE VIVO: 428. Journal of Urology 2009; 181: 153- EA-154-TL
46. Klink, JC, Poulton, S., Antonelli, J., Potter, MQ, Jayachandran, J., Tewari, AK, Febbo, PG, Pizzo, SV, le Freedland, S. RESVERATROL ALTERS PROSTATE CANCER XENOGRAFT KHOLO: 724. Journal ea Urology 2009; 181
47. Ka nepo, K. A. Cannabinoid receptor inverse agonists as new novel Therapeutic agents. "The Sciences and Engineering. The Sciences and Engineering 2009; 70 (4-B)
48. Pregliasco, F. le Cogo, R. [Antioxidant le metsoako ea ho itšireletsa mafung ho batho ba baholo ba kenang ente ea ntaramane ea selemo e ntlafatsa karabelo ea serological le ho fokotsa linako tsa ho hema] L'uso di sostanze antiossidanti ed immunomodulanti in una popolazione anziana so. Cochrane Central Register ea Liteko tse Laoloang 2010;
49. Steigerwald, M. D., Fisk, M. Z., Smoliga, J. M., le Rundell, K. W. Litlamorao tsa Resveratrol On khatello ea oksijene le Ts'ebetso ea Vascular kamora ho ikoetlisa ho ts'ilafatso ea moea o ts'oanang: 2645. Medicine & Science in Sports & Exercise 2011; 43
50. Bost, J., Smoliga, JM, Bost, KM, le Maroon, JC Likhoeli Tse Tharo Tlatsetso ea Molomo ea Tlatsetso e Ikhethileng ea Polyphenol e Ntlafatsa Lipontšo tsa Ts'ebetso ea 'mele le Neurocognitive ho Batho ba Baholo ba Sedentary: 2205. Medicine & Science in Sports & Exercise 2008; 40: S246 .
51. Grujic Milanovic, J., Mihailovic-Stanojevic, N., Miloradovic, Z., Jacevic, V., Milosavljevic, I., Milanovic, S., Ivanov, M., le Jovovic, DJ RESVERATROL E FOKOTSA Khatello ea Mali, LIPHETOHO TSA MOTSOALLE KETSAHALO EA ENZYME LE LITLHAKU TSE KHOLO TSA MOKHOA OA TEKOLO EA MALIGNANT HYPERTENSION PP.29.171. Nalane ea Hypertension 2010; 28
52. Pendurthi, U. R., Williams, J. T., le Rao, L. V. Resveratrol, motsoako oa polyphenolic o fumanoang veineng, o thibela tlhahiso ea methapo liseleng tsa methapo ea kutlo: Monyetla o ka bang teng oa melemo ea pelo le methapo e amanang le tšebeliso e itekanetseng ea veine. Arterioscler Thromb. Vasc. Biol 1999; 19: 419-426 (Khatisitsoeng) Sheba tse sa hlakang.
53. Rotondo, S., Rajtar, G., Manarini, S., Celardo, A., Rotillo, D., de Gaetano, G., Evangelista, V., le Cerletti, C. Phello ea trans-resveratrol, polyphenolic ea tlhaho. motsoako, mosebetsing oa polymorphonuclear leukocyte. Mofumahali Br. J. Pharmacol. 1998; 123: 1691-1699. Sheba tse sa hlakang.
54. Bhatt, J. K., Thomas, S., le Nanjan, M. J. Resveratrol supplementation e ntlafatsa taolo ea glycemic mofuteng oa 2 oa lefu la tsoekere. Phepo e nepahetseng. 2012; 32: 537-541. Sheba tse sa hlakang.
55. Hector, K. L., Lagisz, M., le Nakagawa, S. Phello ea ts'ebetso ea matlafatsong ea bophelo bo bolelele ho mefuta eohle: tlhatlhobo ea meta. Lehe. 10-23-2012; 8: 790-793. Sheba tse sa hlakang.
56. Roehr, B. Mofuputsi oa pelo le methapo o qapile lintlha lithutong tsa veine e khubelu. BMJ 2012; 344: e406. Sheba tse sa hlakang.
57. Crandall, J. P., Oram, V., Trandafirescu, G., Reid, M., Kishore, P., Hawkins, M., Cohen, H. W., le Barzilai, N. Pilot ho ithuta ka resveratrol ho batho ba baholo ba nang le mamello ea tsoekere. J. Gerontol, Biol.Sci.Med.Sci. 2012; 67: 1307-1312. Sheba tse sa hlakang.
58. Fujitaka, K., Otani, H., Jo, F., Jo, H., Nomura, E., Iwasaki, M., Nishikawa, M., Iwasaka, T., le Das, DK Modified resveratrol Longevinex e ntlafatsa ts'ebetso ea ho qetela. ho batho ba baholo ba nang le lefu la ts'oaetso ba fumanang kalafo e tloaelehileng. Limatlafatsi 2011; 31: 842-847. Sheba tse sa hlakang.
59. Linako, S., Konings, E., Bilet, L., Houtkooper, RH, van de Weijer, T., Goossens, GH, Hoeks, J., van der Krieken, S., Ryu, D., Kersten, S ., Moonen-Kornips, E., Hesselink, MK, Kunz, I., Schrauwen-Hinderling, VB, Blaak, EE, Auwerx, J., le Schrauwen, P. Litlamorao tse kang lithibelo tsa kalori ea matsatsi a 30 a tlatsetso ea resveratrol ho metabolism ea matla le profil ea metabolic ho batho ba batenya. Cell Metab 11-2-2011; 14: 612-622. Sheba tse sa hlakang.
60. Xuzhu, G., Komai-Koma, M., Leung, B. P., Howe, H. S., McSharry, C., McInnes, I. B., le Xu, D. Resveratrol modulates murine collagen e bakiloeng ke ramatiki ka ho thibela ts'ebetso ea Th17 le B-cell. Ann.Rheum. Dis 2012; 71: 129-135 (Khatisitsoeng) Sheba tse sa hlakang.
61. Knight, CM, Gutierrez-Juarez, R., Lam, TK, Arrieta-Cruz, I., Huang, L., Schwartz, G., Barzilai, N., le Rossetti, L. Mediobasal hypothalamic SIRT1 e bohlokoa bakeng sa litlamorao tsa resveratrol. ka ketso ea insulin ka likhoto. Lefu la tsoekere 2011; 60: 2691-2700. Sheba tse sa hlakang.
62. Howells, LM, Berry, DP, Elliott, PJ, Jacobson, EW, Hoffmann, E., Hegarty, B., Brown, K., Steward, WP, le Gescher, AJ Phase I, boithuto ba sefofane bo habeli bo foufetseng ba micronized resveratrol (SRT501) ho bakuli ba nang le metastases ea hepatic - polokeho, pharmacokinetics, le pharmacodynamics. Kankere Pele. Res (Phila) 2011; 4: 1419-1425. Sheba tse sa hlakang.
63. Wuertz, K., Quero, L., Sekiguchi, M., Klawitter, M., Nerlich, A., Konno, S., Kikuchi, S., le Boos, N. Veine e khubelu ea polyphenol resveratrol e bonts'a bokhoni bo tšepisang ba kalafo ea bohloko ba mokokotlo oa "pulposus" bo in vitro le in vivo. Mokokotlo (Phila Pa 1976.) 10-1-2011; 36: E1373-E1384. Sheba tse sa hlakang.
64. Brasnyo, P., Molnar, GA, Mohas, M., Marko, L., Laczy, B., Cseh, J., Mikolas, E., Szijarto, IA, Merei, A., Halmai, R., Meszaros, LG, Sumegi, B., le Wittmann, I. Resveratrol e ntlafatsa kutloisiso ea insulin, e fokotsa khatello ea maikutlo le ho kenya tšebetsong tsela ea Akt ea bakuli ba lefu la tsoekere ba mofuta oa 2. Br J Phepo. 2011; 106: 383-389. Sheba tse sa hlakang.
65. Fabbrocini, G., Staibano, S., De, Rosa G., Battimiello, V., Fardella, N., Ilardi, G., La Rotonda, MI, Longobardi, A., Mazzella, M., Siano, M. , Pastore, F., De, Vita, V, Vecchione, ML, le Ayala, F. Resveratrol e nang le gel bakeng sa ho phekola li-acne vulgaris: thuto ea sefofane e sa boneng, e laoloang ke koloi. Ke J Clin. Dermatol 4-1-2011; 12: 133-141. Sheba tse sa hlakang.
66. Kitada, M., Kume, S., Imaizumi, N., le Koya, D. Resveratrol e ntlafatsa khatello ea mali le ho sireletsa khahlano le lefu la tsoekere ka ho tloaela ho se sebetse ha Mn-SOD tseleng e ikemetseng ea AMPK / SIRT1. Lefu la tsoekere 2011; 60: 634-643. Sheba tse sa hlakang.
67. Shindler, K. S., Ventura, E., Dutt, M., Elliott, P., Fitzgerald, D. C., le Rostami, A. Oral resveratrol e fokotsa tšenyo ea methapo ea kutlo ka mohlala oa multiple sclerosis. J Neuroophthalmol. 2010; 30: 328-339. Sheba tse sa hlakang.
68. Brown, VA, Patel, KR, Viskaduraki, M., Crowell, JA, Perloff, M., Booth, TD, Vasilinin, G., Sen, A., Schinas, AM, Piccirilli, G., Brown, K., K'homphieutha. Motsamaisi, WP, Gescher, AJ, le Brenner, DE Pheta phuputso ea tekanyetso ea mofetše oa chemopreventive agent resveratrol ho baithaopi ba phetseng hantle: polokeho, pharmacokinetics, le phello ho insulin e ts'oanang le kholo ea kholo. Kankere Res 11-15-2010; 70: 9003-9011. Sheba tse sa hlakang.
69. Patel, KR, Brown, VA, Jones, DJ, Britton, RG, Hemingway, D., Miller, AS, Bophirimela, KP, Booth, TD, Perloff, M., Crowell, JA, Brenner, DE, Motsamaisi, WP, Gescher, AJ, le Brown, K. Clinical pharmacology ea resveratrol le metabolites ea eona ho bakuli ba mofets'e ba nang le mofets'e. Kankere Res 10-1-2010; 70: 7392-7399. Sheba tse sa hlakang.
70. Knobloch, J., Sibbing, B., Jungck, D., Lin, Y., Urban, K., Stoelben, E., Strauch, J., le Koch, A. Resveratrol e sitisa ho lokolloa ha li-cytokine tse sa thibeleng ho ruruha. ho tloha liseleng tsa mesifa tsa motho tse boreleli tse tsoang moeeng tse sa foleng tsa pulmonary disease. J Pharmacol Tlhaloso. 2010; 335: 788-798. Sheba tse sa hlakang.
71. Chow, HH, Garland, LL, Hsu, CH, Vining, DR, Chew, WM, Miller, JA, Perloff, M., Crowell, JA, le Alberts, DS Resveratrol e hlophisa li-enzyme tsa lithethefatsi le kankere ea kokoana-hloko moithaopi ea phetseng hantle ho ithuta. Kankere Pele. Res (Phila) 2010; 3: 1168-1175. Sheba tse sa hlakang.
72. Wong, R. H., Howe, P. R., Buckley, J. D., Coates, A. M., Kunz, I., le Berry, N. M. Acute resveratrol supplementation e ntlafatsa phallo e tsamaeang ka phallo ho batho ba fetang boima ba 'mele / batho ba batenya haholo ka khatello e phahameng ea mali. Limatlafatsi Metab Cardiovasc. Dis 2011; 21: 851-856. Sheba tse sa hlakang.
73. la, Porte C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., le Cameron, DW Steady-State pharmacokinetics le mamello ea trans-resveratrol 2000 mg habeli ka letsatsi le lijo, quercetin le joala (ethanol) lithutong tse phetseng hantle tsa batho. Kliniki ea Pharmacokinet. 2010; 49: 449-454. Sheba tse sa hlakang.
74. Le Couteur, D.G le Sinclair, D. A. Morero oa ho nts'etsapele mekhoa ea kalafo e eketsang bophelo bo botle le ho liehisa lefu. J Gerontol, Biol.Sci.Med Sci. 2010; 65: 693-694. Sheba tse sa hlakang.
75. Kennedy, DO, Wightman, EL, Reay, JL, Lietz, G., Okello, EJ, Wilde, A., le Haskell, litlamorao tsa CF tsa resveratrol liphetohong tsa phallo ea mali le ts'ebetso ea ts'ebetso ho batho: placebo e foufetseng habeli. -e laoloang, lipatlisiso tsa crossover. Ke J Clin. 2010; 91: 1590-1597. Sheba tse sa hlakang.
76. Daffner, K. R. Ho khothaletsa botsofali bo atlehileng ba ho tseba lintho: tlhahlobo e felletseng. Li-Alzheimers. Dis 2010; 19: 1101-1122. Sheba tse sa hlakang.
77. Yu, H. P., Hwang, T. L., Hwang, T. L., Yen, C. H., le Lau, Y. T. Resveratrol e thibela ho se sebetse ha endothelial le tlhahiso ea aortic superoxide kamora ho tsoa mali ka lebaka la khatello ea maikutlo ka tsela ea hemeoxygenase-1 e amohelang receptor. Tlhokomelo ea Crit Med 2010; 38: 1147-1154. Sheba tse sa hlakang.
78. Albani, D., Polito, L., le Forloni, G. Sirtuins e le liphofu tsa lipale tsa lefu la Alzheimer le mathata a mang a neurodegenerative: bopaki ba liteko le ba lefutso. J Alzheimers. Dis 2010; 19: 11-26 (Khatisitsoeng) Sheba tse sa hlakang.
79. Guo, J. P., Yu, S., le McGeer, P. L. Simple in vitro assays ho khetholla li-amyloid-beta aggregation blockers bakeng sa kalafo ea lefu la Alzheimer. J Alzheimers. Dis. 2010; 19: 1359-1370. Sheba tse sa hlakang.
80. Jha, R. K., Ma, Q., Sha, H., le Palikhe, M. Tšireletso ea ts'ireletso ea resveratrol ka kotsi e matla ea ho fokola ha boko e bakoang ke ho fokola. Liphaka 2009; 38: 947-953. Sheba tse sa hlakang.
81. Zhang, H., Zhang, J., Ungvari, Z., le Zhang, C. Resveratrol e ntlafatsa tšebetso ea endothelial: karolo ea TNF {alpha} le khatello ea methapo ea mali. Arterioscler.Thromb.Vasc.Boloki. 2009; 29: 1164-1171. Sheba tse sa hlakang.
82. Bournival, J., Quessy, P., le Martinoli, M. G. Lits'ireletso tsa resveratrol le quercetin khahlano le MPP + e bakileng khatello ea mali ea khatello ea mali ka ho hlophisa matšoao a lefu la apoptotic ho li-neuron tsa dopaminergic. Cell Mol.Neurobiol. 2009; 29: 1169-1180. Sheba tse sa hlakang.
83. Almeida, L., Vaz-da-Silva, M., Falcao, A., Soares, E., Costa, R., Loureiro, AI, Fernandes-Lopes, C., Rocha, JF, Nunes, T., Wright. , L., le Soares-da-Silva, P. Pharmacokinetic le polokeho ea trans-resveratrol thutong e ntseng e phahama ea litekanyetso tse ngata ho baithaopi ba phetseng hantle. Mol. Nutr.Food Res 2009; 53 Tlatsetso ea 1: S7-15. Sheba tse sa hlakang.
84. Vingtdeux, V., Dreses-Werringloer, U., Zhao, H., Davies, P., le Marambaud, P. Melemo ea kalafo ea resveratrol lefung la Alzheimer's. BMC. Neurosci. 2008; 9 Tlatsetso ea 2: S6. Sheba tse sa hlakang.
85. Fan, E., Zhang, L., Jiang, S., le Bai, Y. Litholoana tsa melemo ea resveratrol ho atherosclerosis. J Med Lijo 2008; 11: 610-614. Sheba tse sa hlakang.
86. Vaz-da-Silva, M., Loureiro, AI, Falcao, A., Nunes, T., Rocha, JF, Fernandes-Lopes, C., Soares, E., Wright, L., Almeida, L., le Soares-da-Silva, P. Phello ea lijo ponong ea pharmacokinetic ea trans-resveratrol. Int. J Clin. Pharmacol. Ka 2008; 46: 564-570. Sheba tse sa hlakang.
87. Dudley, J. I., Lekli, I., Mukherjee, S., Das, M., Bertelli, A. A., le Das, D. K. Na veine e tšoeu e tšoaneleha ho ikhanyetsa ha Fora? Papiso ea litlamorao tsa pelo tsa veine e khubelu le e tšoeu le likarolo tsa tsona: resveratrol, tyrosol le hydroxytyrosol. J Agric. Lijo Chem. 10-22-2008; 56: 9362-9373. Sheba tse sa hlakang.
88. Orallo, F. Trans-resveratrol: setlhare sa boloi sa bocha ba ka ho sa feleng? Mokhubu Chem. 2008; 15: 1887-1898. Sheba tse sa hlakang.
89. Rocha-Gonzalez, H. I., Ambriz-Tututi, M., le Granados-Soto, V. Resveratrol: setsi sa tlhaho se nang le bokhoni ba meriana ea mafu a neurodegenerative. Molemo ka ho Fetisisa CNS.Neurosci. 2008; 14: 234-247. Sheba tse sa hlakang.
90. Calabrese, V., Cornelius, C., Mancuso, C., Pennisi, G., Calafato, S., Bellia, F., Bates, TE, Giuffrida Stella, AM, Schapira, T., Dinkova Kostova, AT, le Rizzarelli, E. Karabelo ea khatello ea lisele tsa cellular: sepheo sa nalane bakeng sa thibelo ea lik'hemik'hale le phepo ea phepo ea botsofali botsofaling, mathata a methapo ea kutlo le bophelo bo bolelele. Neurochem. Res 2008; 33: 2444-2471 (Khatisitsoeng) Sheba tse sa hlakang.
91. Pearson, KJ, Baur, JA, Lewis, KN, Peshkin, L., Theko, NL, Labinskyy, N., Swindell, WR, Kamara, D., Minor, RK, Perez, E., Jamieson, HA, Zhang, Y., Dunn, SR, Sharma, K., Pleshko, N., Woollett, LA, Csiszar, A., Ikeno, Y., Le Couteur, D., Elliott, PJ, Becker, KG, Navas, P., Ingram, DK, Wolf, NS, Ungvari, Z., Sinclair, DA, le de Cabo, R. Resveratrol e liehisa ho senyeha ho amanang le lilemo mme e etsisa likarolo tsa sengoloa tsa thibelo ea lijo ntle le ho eketsa nako ea bophelo. Cell Metab 2008; 8: 157-168. Sheba tse sa hlakang.
92. Dong, W., Li, N., Gao, D., Zhen, H., Zhang, X., le Li, F. Resveratrol e thibela tšenyo ea boko ba kelello ka nako e liehang ka mor'a ho otloa ke lefu le ho susumetsa RNA le protheine bakeng sa angiogenic mabaka. J Vasc Bohloko. 2008; 48: 709-714. Sheba tse sa hlakang.
93. Yu, H. P., Hsu, J. C., Hwang, T. L., Yen, C. H., le Lau, YT T. Resveratrol e thibela likotsi tsa hepatic kamora ho sithabela ha mali ka tsela e amanang le receptor ea estrogen. Ho tsosoa 2008; 30: 324-328. Sheba tse sa hlakang.
94. Bass, T. M., Weinkove, D., Houthoofd, K., Gems, D., le Partridge, L. Liphello tsa resveratrol nakong ea bophelo ho li-elegans tsa Drosophila melanogaster le Caenorhabditis. Mech. Ho Tsofala Dev 2007; 128: 546-552. Sheba tse sa hlakang.
95. Gruber, J., Tang, S. Y., le Halliwell, B.Bopaki ba ho rekisa pakeng tsa ho phela le ho phela hantle 'meleng ho bakoang ke kalafo ea resveratrol ea li-elegans tsa Caenorhabditis. Ann N Y. Acad Sci 2007; 1100: 530-542. Sheba tse sa hlakang.
96. Baur, J. A. le Sinclair, D. A. Melemo ea kalafo ea resveratrol: bopaki ba in vivo. Nat Rev Lithethefatsi. 2006; 5: 493-506. Sheba tse sa hlakang.
97. Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A., Domenici, L., le Cellerino, A. Resveratrol ba lelefatsa bophelo ba bona mme ba thibela ho qala ha matšoao a amanang le lilemo ka mokokotlo oa nakoana. Curr Biol 2-7-2006; 16: 296-300. Sheba tse sa hlakang.
98. Rakici, O., Kiziltepe, U., Coskun, B., Aslamaci, S., le Akar, F. Liphello tsa resveratrol ka molumo oa methapo le ts'ebetso ea ho qetela ea methapo ea motho ea saphenous le methapo ea ka hare ea mammary. Int. J Cardiol 11-2-2005; 105: 209-215 (Khatisitsoeng) Sheba tse sa hlakang.
99. Ma, ZH le Ma, Q. Y. Resveratrol: setlhare sa bongaka bakeng sa pancreatitis e matla. Lefatše J Gastroenterol. 6-7-2005; 11: 3171-3174. Sheba tse sa hlakang.
100. Molnar, V. le Garai, J. Lik'hemik'hale tse tsoang ho limela tse khahlisang limela li ama tšebetso ea MIF tautomerase. Int.Immunopharmacol. 2005; 5: 849-856. Sheba tse sa hlakang.
101. Provinciali, M., Re, F., Donnini, A., Orlando, F., Bartozzi, B., Di Stasio, G., le Smorlesi, A. Phello ea resveratrol ntlafatsong ea lihlahala tsa mammary tse itlelang feela ho HER-2 / litoeba tsa transgenic. Int. J Kankere 5-20-2005; 115: 36-45. Sheba tse sa hlakang.
102. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., le Takada, Y. Karolo ea resveratrol ho thibela le ho phekola mofets'e: lithuto tsa pele le tsa bongaka. Setsi sa likokoana-hloko Res. 2004; 24 (5A): 2783-2840. Sheba tse sa hlakang.
103. Walle, T., Hsieh, F., DeLegge, M.H, Oatis, J. E., Jr., le Walle, U. K. Ho kenella haholo empa ho fokola haholo ka lebaka la tšebeliso ea molomo ea molomo. Ho Laola Metab ea Lithethefatsi. 2004; 32: 1377-1382. Sheba tse sa hlakang.
104. Jannin, B., Menzel, M., Berlot, J. P., Delmas, D., Lancon, A., le Latruffe, N. Tsamaiso ea resveratrol, kankere ea likhemik'hale e thibelang kankere, ho lipheo tsa lisele: plasmatic protein binding and cell uptake. Likokoana-hloko. Pharmacol. 9-15-2004; 68: 1113-1118. Sheba tse sa hlakang.
105. Evers, D. L., Wang, X., Huong, S. M., Huang, D. Y., le Huang, E. S. 3,4 ', 5-Trihydroxy-trans-stilbene (resveratrol) e thibela ho pheta-pheta ha cytomegalovirus ea batho le ho tšoaetsoa ke lisele tsa cellular. Antiviral Res. 2004; 63: 85-95. Sheba tse sa hlakang.
106. Piver, B., Fer, M., Vitrac, X., Merillon, JM, Dreano, Y., Berthou, F., le Lucas, D. Ho kenella ha cytochrome P450 1A2 ho biotransformation ea trans-resveratrol ho li-microsomes tsa sebete sa motho. . Likokoana-hloko. Pharmacol. 8-15-2004; 68: 773-782. Sheba tse sa hlakang.
107. Wood, J. G., Rogina, B., Lavu, S., Howitz, K., Helfand, S. L., Tatar, M., le Sinclair, D. Batšehetsi ba Sirtuin ba etsisa thibelo ea khalori le ho liehisa botsofali ho metazoans. Tlhaho 8-5-2004; 430: 686-689. Sheba tse sa hlakang.
108. Olas, B., Wachowicz, B., Bald, E., le Glowacki, R. Litlamorao tsa ts'ireletso ea resveratrol khahlano le liphetoho tsa mali a li-platelet a mali a hlohlellelitsoeng ke metsoako ea platinamo. J. Physiol Pharmacol. 2004; 55: 467-476. Sheba tse sa hlakang.
109. Cavallaro, A., Ainis, T., Bottari, C., le Fimiani, V. Phello ea ho khutlisetsa ts'ebetsong liketsong tse ling tsa li-neutrophil tsa batho tse ikhethileng. Physiol Res. 2003; 52: 555-562. Sheba tse sa hlakang.
110. Kim, YA, Lee, WH, Choi, TH, Rhee, SH, Park, KY, le Choi, YH Kenyelletso ea p21WAF1 / CIP1, pRB, Bax le NF-kappaB ha ho etsoa ts'oaetso ea kholo le apoptosis ka resveratrol ka lung lung carcinoma Lisele tse A549. Int. J. Oncol. 2003; 23: 1143-1149. Sheba tse sa hlakang.
111. Howitz, KT, Bitterman, KJ, Cohen, HY, Lamming, DW, Lavu, S., Wood, JG, Zipkin, RE, Chung, P., Kisielewski, A., Zhang, LL, Scherer, B., le Sinclair , Baetsi ba limolek'hule tse nyane ba DA ba li-sirtuin ba holisa bophelo ba Saccharomyces cerevisiae. Tlhaho 9-11-2003; 425: 191-196. Sheba tse sa hlakang.
112. Delmas, D., Rebe, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe. , N., le Solary, E. Resveratrol e bakoang ke apoptosis e amahanngoa le ts'ebeliso ea Fas ho li-raft le ho thehoa ha mohaho o bontšang lefu o nang le tšenyo ea lisele tsa kankere ea colon. Mohlomphehi. 10-17-2003; 278: 41482-41490. Sheba tse sa hlakang.
113. Liang, Y. C., Tsai, S. H., Chen, L., Lin-Shiau, S. Y., le Lin, J. K. Resveratrol-hlohlelletsa ho ts'oaroa ha G2 ka thibelo ea CDK7 le p34CDC2 kinases liseleng tsa colon carcinoma HT29. Likokoana-hloko. Pharmacol. 4-1-2003; 65: 1053-1060. Sheba tse sa hlakang.
114. Klinge, C. M., Risinger, K. E., Watts, M. B., Beck, V., Eder, R., le Jungbauer, A. Ts'ebetso ea Estrogenic ka li-extracts tsa veine e tšoeu le e khubelu. J Agric. Lijo Chem 3-26-2003; 51: 1850-1857. Sheba tse sa hlakang.
115. Vitrac, X., Desmouliere, A., Brouillaud, B., Krisa, S., Deffieux, G., Barthe, N., Rosenbaum, J., le Merillon, JM Kabo ea [14C] -trans-resveratrol, a kankere chemopreventive polyphenol, ka lisele tsa toeba kamora ho tsamaisa molomo Bophelo Sci 4-4-2003; 72: 2219-2233. Sheba tse sa hlakang.
116. Levenson, AS, Gehm, BD, Pearce, ST, Horiguchi, J., Simons, LA, Ward, JE, III, Jameson, JL, le Jordan, VC Resveratrol e sebetsa joalo ka agonist ea estrogen receptor (ER) liseleng tsa mofets'e oa matsoele hantle. fetisoa ka alpha ea ER. Int. J. Kankere 5-1-2003; 104: 587-596. Sheba tse sa hlakang.
117. Yu, C., Shin, Y. G., Kosmeder, J. W., Pezzuto, J. M., le van Breemen, R. B. Liquid chromatography / tandem mass spectrometric boikemisetso ba thibelo ea cytochrome ea batho P450 isozymes ka resveratrol le resveratrol-3-sulfate. Ka potlako Commun. 2003; 17: 307-313. Sheba tse sa hlakang.
118. Olas, B., Wachowicz, B., Saluk-Juszczak, J., le Zielinski, T. Phello ea resveratrol, motsoako oa tlhaho oa polyphenolic, ts'ebetsong ea platelet e bakoang ke endotoxin kapa thrombin. Thromb. Res 8-15-2002; 107 (3-4): 141-145. Sheba tse sa hlakang.
119. Wallerath, T., Deckert, G., Ternes, T., Anderson, H., Li, H., Witte, K., le Forstermann, U. Resveratrol, polyphenolic phytoalexin e teng veineng e khubelu, e ntlafatsa polelo le ts'ebetso ea endothelial nitric oxide synthase. Tsamaiso ea 9-24-2002; 106: 1652-1658. Sheba tse sa hlakang.
120. Sharma, M. le Gupta, YK K. Kalafo e sa foleng e nang le trans resveratrol e thibela intracerebroventricular streptozotocin e bakileng ho holofala ha kutloisiso le khatello ea mali ho likhoto. Bophelo Sci 10-11-2002; 71: 2489-2498. Sheba tse sa hlakang.
121. Holian, O., Wahid, S., Atten, M. J., le Attar, B. M. Thibelo ea keketseho ea lisele tsa mofetše oa ka mpeng ka resveratrol: karolo ea nitric oxide. Ke. J. Physiol Gastrointest. Physiol e Pholohang 2002; 282: G809-G816. Sheba tse sa hlakang.
122. Potter, GA, Patterson, LH, Wanogho, E., Perry, PJ, Butler, PC, Ijaz, T., Ruparelia, KC, Konyana, JH, Molemi, PB, Stanley, LA le Burke, MD Moemeli oa thibelo ea mofets'e. resveratrol e fetoloa anticancer moemeli piceatannol ke cytochrome P450 enzyme CYP1B1. Br. J. Kankere 3-4-2002; 86: 774-778. Sheba tse sa hlakang.
123. Falchetti, R., Fuggetta, M. P., Lanzilli, G., Tricarico, M., le Ravagnan, G. Liphello tsa resveratrol ts'ebetsong ea lisele tsa 'mele ea motho. Bophelo Sci. 11-21-2001; 70: 81-96. Sheba tse sa hlakang.
124. Bhavnani, BR, Cecutti, A., Gerulath, A., Woolever, AC, le Berco, M. Ho bapisoa le litlamorao tsa antioxidant tsa li-estrogen tsa equine, likarolo tsa veine e khubelu, vithamine E, le probucol ho oxidation e tlase ea lipoprotein oxidation ho basali ba postmenopausal . Ho khaotsa ho ilela khoeli. 2001; 8: 408-419. Sheba tse sa hlakang.
125. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G., Moon, R. C., le Pezzuto, J. M. Estrogenic le antiestrogenic thepa ea resveratrol mefuteng ea mammary tumor. Kankere Res. 10-15-2001; 61: 7456-7463. Sheba tse sa hlakang.
126. Lee, J. E. le Safe, S. Ho kenya letsoho ha mochini oa kamora ho phetoa ho thibelo ea polelo ea CYP1A1 ka resveratrol liseleng tsa mofetše oa matsoele. Likokoana-hloko. Pharmacol. 10-15-2001; 62: 1113-1124. Sheba tse sa hlakang.
127. Bhat, K. P. le Pezzuto, J. M. Resveratrol e bonts'a thepa ea cytostatic le antiestrogenic e nang le lisele tsa endometrial adenocarcinoma (Ishikawa). Kankere Res. 8-15-2001; 61: 6137-6144. Sheba tse sa hlakang.
128. Nicolini, G., Rigolio, R., Miloso, M., Bertelli, A. A., le Tredici, G. Phello ea anti-apoptotic ea trans-resveratrol ho paclitaxel e bakiloeng ke apoptosis ka seleng ea motho ea neuroblastoma SH-SY5Y. Mahlale. 4-13-2001; 302: 41-44. Sheba tse sa hlakang.
129. Giovannini, L., Migliori, M., Longoni, BM, Das, DK, Bertelli, AA, Panichi, V., Filippi, C., le Bertelli, A. Resveratrol, polyphenol e fumanoang veineng, e fokotsa ts'enyo ea ts'oaetso ea ischemia ho liphio tsa likhoto. J Cardiovasc.Pharmacol. 2001; 37: 262-270. Sheba tse sa hlakang.
130. Chan, W. K. le Delucchi, A. B. Resveratrol, e leng karolo ea veine e khubelu, ke mochini o sa sebetseng oa cytochrome P450 3A4. Bophelo Sci 11-10-2000; 67: 3103-3112. Sheba tse sa hlakang.
131. Wang, M. J., Huang, H. M., Hsieh, S. J., Jeng, K. C., le Kuo, J. S. Resveratrol e thibela tlhahiso ea interleukin-6 liseleng tse kopaneng tsa glial tlasa hypoxia / hypoglycemia e lateloang ke reoxygenation. J Neuroimmunol. 1-1-2001; 112 (1-2): 28-34. Sheba tse sa hlakang.
132. Chang, T. K., Lee, W. B., le Ko, H. H. Trans-resveratrol e hlophisa tšebetso ea catalytic le polelo ea mRNA ea cytochrome ea motho e sebelisang prarcinogen P450 1B1. Na. J. Physiol Pharmacol. 2000; 78: 874-881. Sheba tse sa hlakang.
133. Burkitt, M. J. le Duncan, J. Litlamorao tsa trans-resveratrol ho theho ea hydroxyl-radical e itšetlehileng ka koporo le tšenyo ea DNA: bopaki ba ho qhekella ha hydroxyl-radical le romana, mokhoa oa ho boloka liketso oa glutathione. Arch. Likokoana-hloko. 9-15-2000; 381: 253-263. Sheba tse sa hlakang.
134. Zbikowska, H. M. le Olas, B. Antioxidants e nang le ts'ebetso ea carcinostatic (resveratrol, vithamine E le selenium) ka ho kopanya lipoleiti tsa mali. J Physiol Pharmacol. 2000; 51: 513-520. Sheba tse sa hlakang.
135. Kirk, R. I., Deitch, J. A., Wu, J. M., le Lerea, K. M. Resveratrol e fokotsa liketsahalo tsa pele tsa ho tšoaea ka liplatelete tse hlatsoitsoeng empa ha e na phello e ntle ho platalet lijong tsohle. Lisele tsa Mali Mol. 2000; 26: 144-150. Sheba tse sa hlakang.
136. Bagchi, D., Bagchi, M., Stohs, S. J., Das, D. K., Ray, S. D., Kuszynski, C. A., Joshi, S. S., le Pruess, H. G. Free radicals le peo ea morara proanthocyanidin ntšang: bohlokoa ho bophelo bo botle ba motho le thibelo ea mafu. Toxicology 8-7-2000; 148 (2-3): 187-197. Sheba tse sa hlakang.
137. Bradamante, S., Piccinini, F., Barenghi, L., Bertelli, A. A., De Jonge, R., Beemster, P., le De Jong, J. W. Na resveratrol e baka maemo a amanang le litlhare? Int.J Lisele tsa React. 2000; 22: 1-4. Sheba tse sa hlakang.
138. Naderali, E. K., Doyle, P. J., le Williams, G. Resveratrol e hlohlelletsa vasorelaxation ea methapo ea mesenteric le ea popelo ho tsoa likolobeng tse tšehali. Clin Sci (Lond) 2000; 98: 537-543. Sheba tse sa hlakang.
139. Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., Kelly, J. W., le Sacchettini, J. C. Rational design ea batho ba matla ba li-inhibitors tsa transthyretin amyloid. Nat Struct. Lefu. 2000; 7: 312-321. Sheba tse sa hlakang.
140. Martinez, J. le Moreno, J. J. Phello ea resveratrol, motsoako oa tlhaho oa polyphenolic, ka mefuta ea oksijene e sebetsang le tlhahiso ea prostaglandin. Likokoana-hloko. Pharmacol 4-1-2000; 59: 865-870. Sheba tse sa hlakang.
141. Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T., Telang, N., le Dannenberg, A. J. Resveratrol e thibela ho ngoloa ha cyclooxygenase-2 liseleng tsa mammary epithelial. MOTSOALLE 1999; 889: 214-223. Sheba tse sa hlakang.
142. Dobrydneva, Y., Williams, R. L., le Blackmore, P. F. trans-Resveratrol e thibela tšubuhlellano ea khalsiamo liplatelete tsa batho tse hlohlellelitsoeng ke thrombin. Mofumahali Br. J. Pharmacol. 1999; 128: 149-157. Sheba tse sa hlakang.
143. Ciolino, H. P. le Yeh, G. C. Thibelo ea aryl hydrocarbon-cytochrome P-450 1A1 enzyme e sebetsang le polelo ea CYP1A1 ka resveratrol. Mol. Pharmacol. 1999; 56: 760-767. Sheba tse sa hlakang.
144. Lin, J. K. le Tsai, S. H. Chemoprevention ea mofets'e le lefu la pelo le methapo ka resveratrol. Proc.Natl.Sci.C Council.Repub. China B 1999; 23: 99-106. Sheba tse sa hlakang.
145. Zou, J. G., Huang, Y. Z., Chen, Q., Wei, E. H., Hsieh, T., le Wu, J. M. Resveratrol e thibela phetoho ea oxidative e entsoeng ke ion le ea azo-e qalileng ea oxidative ea lipoprotein tse tlase tsa batho. Likokoana-hloko. Mol. Biol. Int. 1999; 47: 1089-1096. Sheba tse sa hlakang.
146. Rahman, I. Antioxidant tsoelo-pele ea kalafo ho COPD. Ther.Adv.Respir.Dis. 2008; 2: 351-374. Sheba tse sa hlakang.
147. Kimura, Y., Okuda, H., le Kubo, M. Litlamorao tsa li-stilbenes tse ikhethileng ho limela tsa moriana ho arachidonate metabolism le degranulation ho li-leukocyte tsa motho tsa polymorphonuclear. J Ethnopharmacol. 1995; 45: 131-139. Sheba tse sa hlakang.
148. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Garcia-Almagro, FJ, Aviles-Plaza, F., Parra, S., Yanez-Gascon, MJ, Ruiz-Ros, JA, Garcia-Conesa , MT, Tomas-Barberan, FA, le Espin, JC Ts'ebeliso ea tlatsetso ea morara e nang le resveratrol e fokotsa LDL e nang le oksijene le ApoB ho bakuli ba nang le thibelo ea mantlha ea lefu la pelo: ho latela likhoeli tse 6, ho laoloa ke placebo , liteko tse sa sebetseng. Mol.Nutr Lijo Res 2012; 56: 810-821. Sheba tse sa hlakang.
149. Tome-Carneiro, J., Gonzalvez, M., Larrosa, M., Yanez-Gascon, MJ, Garcia-Almagro, FJ, Ruiz-Ros, JA, Garcia-Conesa, MT, Tomas-Barberan, FA le Espin, JC Ts'ebeliso ea selemo se le seng ea moriana oa morara o nang le resveratrol e ntlafatsa maemo a ho ruruha le a fibrinolytic a bakuli ba thibelo ea mantlha ea lefu la pelo. Ke J Cardiol. 8-1-2012; 110: 356-363. Sheba tse sa hlakang.
150. Zern, TL, Wood, RJ, Greene, C., Bophirimela, KL, Liu, Y., Aggarwal, D., Shachter, NS le Fernandez, ML Grape polyphenols e na le tšusumetso ea pelo ho basali ba pele le ba postmenopausal ka ho theola lero la mali lipids le ho fokotsa khatello ea kelello ea oxidative. J Phepo. 2005; 135: 1911-1917. Sheba tse sa hlakang.
151. Piver, B., Berthou, F., Dreano, Y., le Lucas, D. Phapang ea thibelo ea li-enzyme tsa cytochrome P450 ke epsilon-viniferin, lesela la resveratrol: papiso le resveratrol le polyphenols tse tsoang lino tse tahang. Bophelo Sci. 7-18-2003; 73: 1199-1213. Sheba tse sa hlakang.
152. de, Santi C., Pietrabissa, A., Mosca, F., le Pacifici, G. M. Glucuronidation ea resveratrol, sehlahisoa sa tlhaho se teng morara le veine, sebeteng sa motho. Xenobiotica 2000; 30: 1047-1054. Sheba tse sa hlakang.
153. Rosa, F.T, Zulet, M. A., Marchini, J. S., le Martinez, J. A. Bioactive metsoako le litlamorao ho matšoao a ho ruruha bathong. Int J Lijo tsa Sci Nutriti 2012; 63: 749-765. Sheba tse sa hlakang.
154. Chang, T. K., Chen, J., le Lee, W. B. Phapang ea ho thibela le ho se sebetse hoa li-enzyme tsa CYP1 tsa batho ka trans-resveratrol: bopaki ba ts'ebeliso ea ts'ebetso ea CYP1A2. J.Pharmacol.Exp .Ther. 2001; 299: 874-882. Sheba tse sa hlakang.
155. Haholo-holo, J. P., Marre-Fournier, F., Le Bail, J. C., Habrioux, G., le Chulia, A. J. Estrogenic / antiestrogenic le thepa e senyang ea (E) - le (Z) -resveratrol. Bophelo Sci. 1-21-2000; 66: 769-777. Sheba tse sa hlakang.
156. Mueller SO, Simon S, Chae K, le al. Li-phytoestrogens le li-metabolite tsa tsona tsa batho li bonts'a likarolo tse fapaneng tsa agonistic le antagonistic ho estrogen receptor alpha (ERalpha) le ERbeta liseleng tsa motho. Toxicol Sci 2004; 80: 14-25. Sheba tse sa hlakang.
157. Boocock DJ, Faust GE, Patel KR, et al. Mokhahlelo oa I oa ho nyolla li-pharmacokinetic ho baithaopi ba phetseng hantle ba resveratrol, e ka bang moemeli oa mofets'e oa chemopreventive. Kankere ea Epidemiol Biomarkers Prev 2007; 16: 1246-52. Sheba tse sa hlakang.
158. Li-MM tsa Lyons, Yu C, Toma RB, et al. Resveratrol ka li-blueberries tse tala le tse halikiloeng le li-bilberry. J Agric Lijo Chem 2003; 51: 5867-70. Sheba tse sa hlakang.
159. Trincheri NF, Nicotra G, Follo C, le al. Resveratrol e baka lefu la sele ka har'a lisele tsa mofets'e tse mebala-bala ka tsela e ncha e amang lysosomal cathepsin D. Carcinogenesis 2007; 28: 922-31. Sheba tse sa hlakang.
160. Scarlatti F, Sala G, Somenzi G, et al. Resveratrol e kenyelletsa kholo ea ho thibela le apoptosis liseleng tsa kankere ea matsoele ea metastatic ka de novo ceramide signaling. FASEB J 2003; 17: 2339-41. Sheba tse sa hlakang.
161. Wang Q, Li H, Wang XW, le al. Resveratrol e khothaletsa phapang mme e hlohlelletsa apoptosis e ikemetseng ea Fas ea lisele tsa motho tsa medulloblastoma. Letšoao la Neurosci Lett 2003; 351: 83-6. Sheba tse sa hlakang.
162. Culpitt SV, Rogers DF, Fenwick PS le ba bang. Thibelo ea tlhahiso ea veine e khubelu, resveratrol, ea cytokine e hlahisoang ke alveolar macrophages ho COPD. Thorax 2003; 58: 942-6. Sheba tse sa hlakang.
163. Pervaiz S. Resveratrol: ho tloha lifateng tsa morara ho isa ho baeloji ea mammalian. FASEB J 2003; 17: 1975-85. Sheba tse sa hlakang.
164. Savaskan E, Olivieri G, Meier F, le al. Sesebelisoa sa veine e khubelu resveratrol e sireletsa ho beta-amyloid neurotoxicity. Gerontology 2003; 49: 380-3. Sheba tse sa hlakang.
165. Gao X, Deeb D, Media J, le al. Ketsahalo ea ho itšireletsa mafung ea resveratrol: e sa lumellaneng ka vitro le ka vivo litlamorao tsa mmele. Biochem Pharmacol 2003; 66: 2427-35. Sheba tse sa hlakang.
166. Schriever C, Pendland SL, Mahady GB. Veine e khubelu, resveratrol, Chlamydia pneumoniae le khokahano ea Fora. Atherosclerosis 2003; 171: 379-80. Sheba tse sa hlakang.
167. Ziegler CC, Metsi a pula L, Whelan J, McEntee MF. Li-resveratrol tsa lijo ha li ame ho ruruha ha mala ka har'a litoeba tsa Apc (Min / +). J Phekolo 2004; 134: 5-10. Sheba tse sa hlakang.
168. Kim YA, Choi BT, Lee YT, le al. Resveratrol e thibela ho ata ha sele mme e baka apoptosis ea lisele tsa motho ea carcinoma MCF-7. Oncol Rep 2004; 11: 441-6. Sheba tse sa hlakang.
169. Zhang Y, Jayaprakasam B, Seeram NP, le al. Ho thibela insulin le cyclooxygenase enzyme e thibeloang ke lik'hemik'hale tsa letlalo tsa cabernet sauvignon. J Agric Lijo Chem 2004; 52: 228-33. Sheba tse sa hlakang.
170. Opipari AW Jr, Tan L, Boitano AE, et al. Autophagocytosis e bakoang ke Resveratrol ka lisele tsa mofetše oa mahe a bomme. Kankere Res 2004; 64: 696-703. Sheba tse sa hlakang.
171. Abou-Zeid LA, El-Mowafy AM. Ho amohela phapang ea li-isomers tsa resveratrol ke motho ea amohelang estrogen-alpha: bopaki ba matla a limolek'hule bakeng sa tlamo ea stereoselective ligand. Boits'oaro 2004; 16: 190-5. Sheba tse sa hlakang.
172. Meng X, Maliakal P, Lu H, et al. Mefuta ea Urinary le plasma ea resveratrol le quercetin bathong, litoeba le likhoto kamora ho kenella ha metsoako e hloekileng le lero la morara. J Agric Lijo Chem 2004; 52: 935-42. Sheba tse sa hlakang.
173. Hascalik S, Celik O, Turkoz Y, le al. Resveratrol, veine e khubelu e nang le polyphenol, e sireletsa tšenyo ea ischemia-reperfusion ea mae a bomme. Gynecol Obstet Invest 2004; 57: 218-23. Sheba tse sa hlakang.
174. Ahmad KA, Clement MV, Hanif IM, Pervaiz S. Resveratrol e thibela apoptosis e bakoang ke lithethefatsi liseleng tsa kankere ea mali ea motho ka ho theha sebaka se kenang seleng se sa lumellaneng le lefu. Kankere Res 2004; 64: 1452-9. Sheba tse sa hlakang.
175. Li W, Seifert M, Xu Y, Hock B. Boithuto bo bapisang ba matla a estrogenic a estradiol, tamoxifen, bisphenol-A le resveratrol e nang le li-bioassays tse peli tsa vitro. Tikoloho Int 2004; 30: 329-35. Sheba tse sa hlakang.
176. Martin AR, Villegas I, La Casa C, ea la Lastra CA. Resveratrol, polyphenol e fumanoang morareng, e hatella tšenyo ea oxidative mme e hlohlelletsa apoptosis nakong ea ho ruruha ha colonic ea pele ho likhoto. Biochem Pharmacol 2004; 67: 1399-410. Sheba tse sa hlakang.
177. Szewczuk LM, Forti L, Stivala LA, Penning TM.Resveratrol ke peroxidase Mediated inactivator ea COX-1 empa eseng COX-2: Mokhoa o sebetsang oa ho rala li-agent tse khethiloeng tsa COX-1. J Biol Chem. 2004; 279: 22727-37. Sheba tse sa hlakang.
178. Wang Z, Huang Y, Zou J, le al. Liphello tsa veine e khubelu le veine ea polyphenol resveratrol ho platelet aggregation ho vivo le in vitro. Int J Mol Med 2002; 9: 77-9. Sheba tse sa hlakang.
179. Mokni M, Limam F, Elkahoui S, le al. Phello e matla ea ts'ireletso ea pelo ea resveratrol, veine e khubelu ea polyphenol, lipelong tse ikhethileng tsa likhoto kamora ho lemala ha ischemia / reperfusion. Arch Biochem Biophys 2007; 457: 1-6. Sheba tse sa hlakang.
180. Elmali N, Baysal O, Harma A, le al. Liphello tsa resveratrol ka ramatiki ea ho ruruha. Ho ruruha 2007; 30: 1-6. Sheba tse sa hlakang.
181. Bujanda L, Garcia-Barcina M, Gutierrez-de Juan V, le al. Phello ea resveratrol ho lefu le bakoang ke joala le liso tsa sebete ho litoeba. BMC Gastroenterol 2006; 6:35. Sheba tse sa hlakang.
182. Baur JA, Pearson KJ, Theko NL, et al. Resveratrol e ntlafatsa bophelo bo botle le pholoho ea litoeba lijong tse nang le likhalori tse ngata. Tlhaho 2006; 444: 337-42. Sheba tse sa hlakang.
183. Murias M, Handler N, Erker T, le al. Li-analogues tsa Resveratrol joalo ka li-cyclooxygenase-2 inhibitors tse khethiloeng: kamano ea tšebetso le sebopeho. Bioorg Med Chem 2004; 12: 5571-8. Sheba tse sa hlakang.
184. Hwang D, Fischer NH, Jang BC, le al. Thibelo ea polelo ea inducible cyclooxygenase le proinfigueatory cytokines ka sesquiterpene lactones ho macrophages e tsamaellana le thibelo ea MAP kinases. Biochem Biophys Res Commun 1996; 226: 810-8 .. Sheba tse sa bonahaleng.
185. Takada Y, Bhardwaj A, Potdar P, Aggarwal BB. Lisebelisoa tse khahlanong le ho ruruha tse sa sebetseng li fapana ka bokhoni ba tsona ba ho hatella ts'ebetso ea NF-kappaB, thibelo ea polelo ea cyclooxygenase-2 le cyclin D1, le ho tlosoa ha kholo ea lisele tsa hlahala. Oncogene 2004; 23: 9247-58. Sheba tse sa hlakang.
186. DM ea Goldberg, Yan J, Soleas GJ. Ho monya li-polyphenol tse tharo tse amanang le veine lithutong tse tharo tse fapaneng ka lithuto tse phetseng hantle. Clin Biochem 2003; 36: 79-87 .. Sheba tse sa bonahaleng.
187. Tokomane JJ, Fu MM, Stiffler BS, et al. Resveratrol inhibition ea phetiso ea vaerase simplex virus. Likokoana-hloko Res 1999; 43: 145-55. Sheba tse sa hlakang.
188. Bowers JL, Tyulmenkov VV, Jernigan SC, Klinge CM. Resveratrol e sebetsa e le motsoako oa agonist / mohanyetsi oa li-estrogen receptors alpha le beta. Endocrinology 2000; 141: 3657-67.
189. Piver B, Berthou F, Dreano Y, Lucas D. Ho thibela mesebetsi ea CYP3A, CYP1A le CYP2E1 ka resveratrol le likarolo tse ling tse sa fetoheng tsa veine e khubelu. Toxicol Lett 2001; 125: 83-91. Sheba tse sa hlakang.
190. Laden BP, Porter TD. Resveratrol e thibela motho oa squalene monooxygenase. Metsoako Res 2001; 21: 747-53.
191. Kozuki Y, Miura Y, Yagasaki K. Resveratrol e hatella tlhaselo ea sele ea hepatoma ntle le ts'ebetso ea eona e khahlanong le ho ata. Cancer Lett 2001; 167: 151-6. Sheba tse sa hlakang.
192. Schneider Y, Vincent F, Duranton B, le al. Phello e khahlano le ho ata ha resveratrol, e leng karolo ea tlhaho ea morara le veine, liseleng tsa mofetše oa batho tsa colonic. Kankere Lett 2000; 158: 85-91.
193. Jacobson JS, Troxel AB, Evans J, le al. Teko e sa reroang ea cohosh e ntšo bakeng sa kalafo ea mahlaseli a chesang har'a basali ba nang le nalane ea mofets'e oa matsoele. J Clin Oncol 2001; 19: 2739-45 (Khatisitsoeng) Sheba tse sa hlakang.
194. Holmes-McNary M, Baldwin AS, Jr.Litšireletso tsa chemoprese tsa trans-resveratrol li amahanngoa le thibelo ea ts'ebetso ea IkappaB kinase. Kankere ea 2000; 60: 3477-83. Sheba tse sa hlakang.
195. Bertelli AA, Giovannini L, Giannessi D, le al. Mosebetsi oa antiplatelet oa maiketsetso le tlhaho ea tlhaho ho veine e khubelu. Int J Tissue React 1995; 17: 1-3. Sheba tse sa hlakang.
196. Gehm BD, McAndrews JM, Chien PY, Jameson JL. Resveratrol, motsoako oa polyphenolic o fumanoang morara le veine, ke agonist bakeng sa receptor ea estrogen. Proc Natl Acad Sci U S A 1997; 94: 14138-43. Sheba tse sa hlakang.
197. Carbo N, Costelli P, Baccino FM, le al. Resveratrol, sehlahisoa sa tlhaho se teng ka har'a veine, se fokotsa kholo ea hlahala mokhoeng oa hlahala ea rat. Likokoana-hloko tsa Biophys Res Commun 1999; 254: 739-43. Sheba tse sa hlakang.
198. Huang C, Ma WY, Goranson A, Dong Z. Resveratrol e hatella phetoho ea sele mme e baka apoptosis ka tsela e itšetlehileng ka p53. Carcinogenesis 1999; 20: 237-42. Sheba tse sa hlakang.
199. Davy BM, Melby CL, Beske SD, le al. Ts'ebeliso ea oat ha e ame ho phomola ha pelo le khatello ea mali ea 24-h ho banna ba nang le khatello e phahameng ea mali ho ea boemong ba khatello ea mali. J Nutriti 2002; 132: 394-8 .. Sheba tse sa hlakang.
200. Chen CK, Pace-Asciak CR. Ketsahalo ea Vasorelaxing ea resveratrol le quercetin ka rat aorta e ka thoko. Gen Pharmacol 1996; 27: 363-6. Sheba tse sa hlakang.
201. Bertelli A, Bertelli AA, Gozzini A, Giovannini L. Plasma le likhakanyo tsa li-resveratrol le lisebelisuoa tsa bongaka. Lithethefatsi Exp Clin Res 1998; 24: 133-8. Sheba tse sa hlakang.
202. Pace-Asciak CR, Hahn S, Diamandis EP, le al. Veine e khubelu ea phenolics trans-resveratrol le quercetin li thibela pokello ea platelet ea motho le eicosanoid synthesis: se boleloang ke ts'ireletso khahlanong le lefu la pelo. Kliniki Chim Acta 1995; 235: 207-19. Sheba tse sa hlakang.
203. Bertelli AA, Giovannini L, Bernini W, et al. Ketsahalo ea antiplatelet ea cis-resveratrol. Lithethefatsi Exp Clin Res 1996; 22: 61-3. Sheba tse sa hlakang.
204. Pace-Asciak CR, Rounova O, Hahn SE, le al. Veine le maro a eona a morara e le li-modulator tsa pokello ea platelet lithutong tse phetseng hantle tsa batho. Kliniki Chim Acta 1996; 246: 163-82. Sheba tse sa hlakang.
205. Jang M, Cai L, Udeani GO, et al. Kankere ea lik'hemik'hale e thibelang lik'hemik'hale tsa resveratrol, sehlahisoa sa tlhaho se tsoang morara. Mahlale 1997; 275: 218-20. Sheba tse sa hlakang.
206. Soleas GJ, Diamandis EP, DM ea Goldberg. Resveratrol: molek'hule eo nako ea eona e fihlileng? Mme o tsamaile? Kliniki ea Likokoana-hloko 1997; 30: 91-113. Sheba tse sa hlakang.
207. Agri Res Svc: Boitsebiso ba Dr. Duke's phytochemical and ethnobotanical database. www.ars-grin.gov/duke (E fihletsoe ka la 3 Pulungoana 1999).
208. Tlhahlobo ea Lihlahisoa tsa Tlhaho ka Lintlha le Lipapiso. St. Louis, MO: Wolters Kluwer Co., 1999.
209. Foster S, Tyler VE. Litlama tse Tšepahalang tsa Tyler: Tataiso e Utloahalang ea Ts'ebeliso ea Litlama le Lipheko tse Amanang le Eona. 3rd ed., Binghamton, NY: Haworth Herbal Press, 1993.
210. Newall CA, Anderson LA, Philpson JD. Meriana ea Litlama: Tataiso bakeng sa Litsebi tsa Bophelo bo Botle. London, UK: Khatiso ea Meriana, 1996.
211. Tyler VE. Litlama tsa Khetho. Binghamton, NY: Khatiso ea Lihlahisoa tsa Meriana, 1994.
212. Blumenthal M, ea hlophisitsoeng. Khomishene e Felletseng ea Jeremane E Monographs: Tataiso ea Phekolo ea Meriana ea Litlama. Fetela. S. Klein. Boston, MA: Lekhotla la Botanical la Amerika, 1998.
213. Monographs mabapi le ts'ebeliso ea meriana ea lithethefatsi. Exeter, UK: European Scientific Co-op Phytother, 1997.

Qetellong ho hlahlojoa - 09/30/2020